This case series describes the medical management of four pregnant women wi
th active multidrug-resistant tuberculosis. None of the four patients were
infected with human immunodeficiency virus. Three patients had disease due
to multidrug-resistant Mycobacterium tuberculosis, and one had disease due
to multidrug-resistant Mycobacterium bovis. Only one patient (patient 3) be
gan retreatment during pregnancy, because her organism was susceptible to t
hree antituberculosis drugs that were considered nontoxic to the fetus. Des
pite concern over teratogenicity of the second-line antituberculosis medica
tions, careful timing of treatment initiation resulted in clinical cure for
the mothers, despite some complications due to chronic tuberculosis and/or
therapy. All infants were born healthy and remain free of tuberculosis. Pr
egnancy and multidrug-resistant tuberculosis need not be a public health di
saster, as both conditions can be managed concurrently and successfully.